Ethylenediamine diacetate for injection

1. Inhibit plasminogen activators, so that plasminogen cannot be activated into plasmin, thereby inhibiting the dissolution of fibrin and producing a hemostatic effect; 2. Promote the release of active substances by platelets, enhance platelet aggregation and adhesion, shorten coagulation time, and produce a hemostatic effect; 3. Enhance capillary resistance, reduce capillary permeability, and thus reduce bleeding.

Ethylenediamine diacetate.

It is suitable for the prevention and treatment of bleeding due to various reasons, and has good effects on surgical bleeding, surgical bleeding, respiratory bleeding, bleeding of the five sense organs, gynecological bleeding, hemorrhoidal bleeding, urinary tract bleeding, cancer bleeding, digestive tract bleeding, and cerebral hemorrhage.

1. Intramuscular injection: 200 mg each time, 1-2 times a day, diluted with water for injection; 2. Intravenous injection: 400 mg each time, 1-2 times a day, diluted with 20 ml of 5% glucose injection solution; 3. Intravenous drip: the usual dose is 600 mg each time (or as prescribed by the doctor), the maximum daily limit is 1200 mg, dissolved and diluted with 250-500 ml of 5% glucose injection solution for use.

The possible adverse reactions of this product include dizziness, slow heart rate, fatigue, skin numbness, fever, dry mouth, vomiting, nausea, etc. Most of them can disappear on their own or after stopping the drug.

It is contraindicated for those who are allergic to this product or medicines containing this product.

Not yet clear.

Keep away from light and store in a sealed container.

0.4g

Beijing Sihuan Kebao Pharmaceutical Co., Ltd.

• Founded in:

  1998-12-04

• Address:

  No. 11, Haiying Road, Science and Technology Park, Fengtai District, Beijing [Park]

• Tax NO.:

  91110106700101574K

• Registered Funds:

  150 million yuan

• Website:

  Log in to view

• Email:

  Log in to view